Prime Medicine (PRME)

• Market cap: $749M
• 1 day: 2.98%
• 5 days: -10.94%
• 1 month: 23.15%
• 3 months: -8.59%
• 6 months: 8.36%
• Year to date: 17.56%
• 1 year: 50.91%
• 5 years: -73%
• 10 years: -73%
• Sector: Healthcare
• Industry: Biotechnology

About: Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.

Employees: 214